Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

75.25 +0.48 (+0.64%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
49 50 Next >
News headline image
2 Growth Stocks to Buy Hand Over Fist in April ↗
These healthcare companies' target markets substantially overlap. 
Via The Motley Fool
News headline image
7 Nasdaq Stocks to Sell in April Before They Crash & Burn ↗
The momentum in growth companies is likely to run out. Move on from these Nasdaq stocks to sell in April before it's too late. 
Via InvestorPlace
News headline image
Dexcom Publishes Annual Sustainability Report
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
News headline image
DexCom Inc Chart Analysis ↗
Technical analysis of the stock chart for DXCM. 
Via Talk Markets
News headline image
Here's How Much $1000 Invested In DexCom 15 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
NASDAQ:DXCM—Positioned as a High-Growth Stock, Ready for a Potential Breakout. ↗
DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating. 
Via Chartmill
News headline image
DexCom Stock Gains from GLP-1 Diabetic Users
DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People 
Via MarketBeat
News headline image
3 Overvalued S&P 500 Stocks for Your ‘Do NOT Buy’ List ↗
The S&P 500’s current P/E ratio is 30% higher than a year ago, making it easier to find overvalued S&P 500 stocks to buy. 
Via InvestorPlace
Topics Stocks
News headline image
Micron, Dropbox And 2 Other Stocks Insiders Are Selling ↗
The Nasdaq 100 closed lower by around 0.1% on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
Market Cap Game Show: Andy Cross vs. Bill Mann ↗
Join the "Rule Breaker Investing" fun. 
Via The Motley Fool
News headline image
DexCom's Options: A Look at What the Big Money is Thinking ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years ↗
 
Via Benzinga
News headline image
Analyst Expectations For DexCom's Future ↗
 
Via Benzinga
News headline image
Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good. ↗
Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year. 
Via Investor's Business Daily
News headline image
Two Hot AI Stocks Lead S&P 500 Monday ↗
Super Micro and Micron , two big winners in 2024, led the way Monday. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
News headline image
More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’ ↗
Investors should take notice of these stocks with high analyst ratings. It's time to load up your portfolio. 
Via InvestorPlace
News headline image
S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind ↗
DexCom, Blackstone and Royal Caribbean head this list of five stocks. 
Via Investor's Business Daily
Topics Economy Stocks
News headline image
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark ↗
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81. 
Via Investor's Business Daily
News headline image
DexCom Stock Trying To Close In On Key Technical Benchmark ↗
In a welcome move, medical device DexCom stock saw its Relative Strength Rating improve from 68 to 73 on Monday. 
Via Investor's Business Daily
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
DexCom Is 'Expanding Rapidly' With Multi-Year Runway Ahead, Bullish Analyst Says ↗
DexCom Inc’s (NASDAQ: DXCM) Stelo Glucose Biosensor System has been approved by the Food and Drug Administration (FDA) as the first over-the-counter (OTC) 
Via Benzinga
News headline image
Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher ↗
On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78. 
Via Investor's Business Daily
News headline image
ServiceNow Setting Up As Three Stocks Flash Buy Signals ↗
All four stocks to watch boast solid earnings growth. 
Via Investor's Business Daily
News headline image
2 Medical Device Stocks to Buy Hand Over Fist in March ↗
Don't let their modest gains over the past year mislead you; these stocks can make for great long-term investments. 
Via The Motley Fool
News headline image
Palantir Technologies, SL Green Realty And A Healthcare Stock On CNBC's 'Final Trades' ↗
On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management named SL Green Realty Corp. 
Via Benzinga
News headline image
FDA Approval For DexCom's Stelo Opens Continuous Glucose Monitoring To Masses, Analyst Expects Competitive Pricing Against Abbott's ↗
FDA greenlights DexCom's Stelo, the first OTC continuous glucose monitor for non-insulin-dependent diabetics. Competitive pricing, potential HSA benefits, and market expansion make it a significant... 
Via Benzinga
News headline image
Stocks Surge, Gold Hits New All-Time High, Bitcoin Reclaims $67,000 As Powell Reassures Wall Street: What's Driving Markets Wednesday? ↗
Markets rallied across the board on Wednesday, erasing the uptick in volatility seen in the previous session, following reassurances from Fed Chair Jerome Powell regarding the Fed’s willingness to ease... 
Via Benzinga
Topics Economy
News headline image
Why Dexcom — And The Obesity Market — Could Benefit From This New FDA Win ↗
The FDA granted Dexcom's Stelo a broad clearance, meaning people without diabetes can use it. 
Via Investor's Business Daily
News headline image
FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription ↗
FDA-approved Dexcom Stelo: Over-the-counter glucose monitoring for non-insulin users. Stelo, the first OTC CGM, available online without prescription from summer 2024. Continuous glucose tracking with... 
Via Benzinga
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.